3 Biotech Stocks Under $4 That Could Surge Over 50%
3 "Strong Buy" Penny Stocks With Triple-Digit Upside
3 Biotech Stocks Under $4 With Massive Upside Ahead
Can Digital Therapeutics Save the Future of Healthcare?
Will China become a global innovation champion? Keeping the global innovation system open will be key
3 Biotech Stocks Under $4 With at Least 50% Upside Potential
The US to waste coronavirus stimulus money on fossil fuels
Live Nation Announces $1.2B Debt Offering, Business Severely Affected by Covid-19 Crisis
Biotech’s Golden Moment
Time To Build Without VCs
Pitt researchers create durable, washable textile coating that can repel viruses
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
FDA issues two guidances to accelerate Covid-19 treatments
Epic CEO Judy Faulkner on developing new therapies for COVID-19
Can Monopoly Money Save the Stock Market? Or Will It Buy Stagnation?
Bristol Myers Squibb CEO Giovanni Caforio On COVID-19 Vaccines
Fintech can help in the response to COVID-19. But where should policymakers start?
Health inequities magnified during COVID-19 pandemic
Why MyoKardia (MYOK) Stock Could Rise Another 30%
3 Biotech Stocks Under $3 With 200%-Plus Upside Potential
Emerging from the Great Lockdown in Asia and Europe
DAX attacks 11,000 on COVID-19 treatment hopes - sustainable?
GW Pharma Pops 9% After-Hours As Epidiolex Smokes Expectations
Telehealth during COVID-19 may lead to better outcomes for diabetes patients
Telehealth tools developed for Ebola improve COVID-19 care
Macro Briefing | 11 May 2020
Solid Biosciences: Keep Your Eyes On The Prize Says Top Analyst
Seres Therapeutics Reports Weak Earnings, But Significant Upside Lies Ahead
ON Semiconductor Quarterly Earnings Miss Amid Virus Pandemic, Sees Orders Coming Back
Quidel’s Rapid Covid-19 Antigen Test Scores Emergency FDA Approval